1. A Retrospective Cohort Study of Disparities in Urine Drug Testing During the Perinatal Period in an Urban, Academic Medical Center.
- Author
-
Ganetsky, Valerie S., Yates, Brianna, Salzman, Matthew, Heil, Jessica, Jones, Iris, Hunter, Krystal, Perry, Robin L., and Baston, Kaitlan E.
- Subjects
- *
MATERNAL health services , *ACADEMIC medical centers , *T-test (Statistics) , *MULTIPLE regression analysis , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *WHITE people , *MANN Whitney U Test , *CHI-squared test , *DRUG use testing , *LONGITUDINAL method , *ODDS ratio , *BLACK people , *PRENATAL care , *RACE , *URINALYSIS , *METROPOLITAN areas , *MEDICAL records , *ACQUISITION of data , *HEALTH equity , *CONFIDENCE intervals , *COMPARATIVE studies , *DATA analysis software - Abstract
The purpose of this study was to evaluate disparities in urine drug testing (UDT) during perinatal care at a single academic medical center. This retrospective cohort study included patients who had a live birth and received prenatal care at our institution between 10/1/2015 and 9/30/2020. The primary outcomes were maternal UDT during pregnancy (UDTPN) and UDT only at delivery (UDTDEL). Secondary outcomes included the number of UDTs (UDTNUM) and the association between a positive UDT test result and race/ethnicity. Mixed model logistic regression and negative binomial regression with clustering based on prenatal care locations were used to control for confounders. Of 6,240 live births, 2,265 (36.3%) and 167 (2.7%) received UDTPN and UDTDEL, respectively. Black (OR 2.09, 95% CI 1.54–2.84) and individuals of Other races (OR 1.64, 95% CI 1.03–2.64) had greater odds of UDTPN compared to non-Hispanic White individuals. Black (beta = 1.12, p < 0.001) and Hispanic individuals (beta = 0.78, p < 0.001) also had a positive relationship with UDTNUM. Compared to individuals with non-Medicaid insurance, those insured by Medicaid had greater odds of UDTPN (OR 1.66, 95% CI 1.11–2.49) and had a positive relationship with UDTNUM (beta = 0.89, p < 0.001). No significant associations were found for UDTDEL and race/ethnicity. Despite receiving more UDT, Black individuals were not more likely to have a positive test result compared to non-Hispanic White individuals (OR 0.95, 95% CI 0.72–1.25). Our findings demonstrate persistent disparities in substance use testing during the perinatal period. Significance: What is already known on this subject?: Prior literature has shown evidence of racial disparities in urine drug testing during pregnancy-related hospital admissions and at delivery. What this study adds?: This paper found that disparities in urine drug testing also exist during the prenatal care period at an urban academic institution. We also found a positive relationship between the number of tests received and being of Black or Hispanic race/ethnicity. Future research should investigate health care system-related interventions to mitigate disparities in urine drug testing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF